Skip to main content
Caplight Logo









Nilo Saúde

Nilo Saúde

Private
São PauloHealthcare & Life Scienceshttps://www.nilosaude.com.br/

Last Round

Series A

Jan 28, 2022

Total Funding Raised

$12M

Company Overview

Nilo Saúde is a healthtech company that provides a SaaS platform for patient engagement and care navigation for healthcare organizations in Brazil.

Sector

Healthcare & Life Sciences

Verticals

Patient Engagement, Vertical SaaS, Healthcare Analytics, Medical AI, CRM

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

B2B SaaScare navigationhealth techpatient engagement platformhealthcare CRMvertical SaaSpatient journey managementpopulation healthhealthcare AIBrazilian health techAI agentshealthcare automationhealthcare analyticsclinical dashboardswhite-label platform

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nilo Saúde Comparables

Compare Nilo Saúde with similar companies based on industry and business-model similarity.

Nilo Saúde comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Axenya
76%
honco
71%
Conexa Saúde
71%

Nilo Saúde Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJan 28, 2022
SeedApr 1, 2020

Key People

Founding team and executive leadership

Cesar Nobre

Chief Technology Officer

Executive Team

Leonardo Ribeiro de Castro Carvalho

CTO

Executive Team

Nilo Saúde Investors

Notable investors and investment history

Nilo Saúde investors
InvestorRounds
Two Culture CapitalSeries A
Global Founders CapitalSeries A
MAYA CapitalSeries A, Seed
Everywhere VenturesSeries A
Tau VenturesSeries A
Upload VenturesSeries A
SoftBank SBLA Advisers Corp.Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 15, 2026

    Monthly visitors increased 34% MoM, reaching 1.7K.

  • Mar 4, 2026

    Monthly visitors increased 81% MoM.

Nilo Saúde Filings

Explore SEC and related filing metadata, where available.

Nilo Saúde filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Nilo Saúde's valuation, stock price, and market status.

Is Nilo Saúde a public or private company?

Nilo Saúde is a private company.

What is the current stock price of Nilo Saúde?

Nilo Saúde is a private company with no public stock price. No recent secondary market data is available.

How much is Nilo Saúde worth (valuation)?

Valuation information for Nilo Saúde is not publicly available.

Can I buy Nilo Saúde stock?

Nilo Saúde shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Nilo Saúde's last funding round?

Nilo Saúde's most recent funding round was Series A on January 28, 2022.

Who are the main investors in Nilo Saúde?

Investor information for Nilo Saúde is not publicly disclosed.

Will Nilo Saúde IPO soon?

No public IPO plans have been announced for Nilo Saúde.

How can I track Nilo Saúde secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nilo Saúde's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSão Paulo
Employee Range195
Year Founded2020
Last FundingJan 28, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?